Hyflux

SINGAPORE (June 10): One of the last things we used to do before closing each issue of The Edge Singapore in our early days was hammer out a little column called “Behind the Stories”. As its name suggests, its purpose was to explain why we had pursued

SINGAPORE (June 3): Embattled water treatment company Hyflux has won yet another reprieve, albeit a brief one, as its debt moratorium has been extended to Aug 2. The company had applied to the courts for a four-month extension on the moratorium, which was

SINGAPORE (May 28): Embattled water company, Hyflux on Tuesday clarified in a Singapore Exchange filing that its recent meeting with Utico did not entail any binding agreements or conclusive number on how much its investors will be getting.

SINGAPORE (May 16): Hyflux on Wednesday announced it had received a non-binding letter of interest from a potential investor to acquire certain of the company’s assets in Algeria and Oman, as well as other assets in the Middle East and North Africa regi

SINGAPORE (Apr 29): Debt-laden water company Hyflux has been given a month’s extension on its debt moratorium, instead of the three months it applied for.

(Apr 26): The collapse of Singapore’s water treatment firm Hyflux has increased investor scrutiny over other debt-laden companies that have sold bonds in the local currency.

SINGAPORE (Apr 22): Announcements continue to be made thick and fast in the ongoing Hyflux saga. The Public Utilities Board (PUB) announced on April 17 plans to take over the Tuaspring desalination plant in 30 days. The national water agency, which has a

SINGAPORE (Apr 17): National water agency PUB has issued a notice to terminate its water purchase agreement with Hyflux subsidiary Tuaspring and take over the Tuaspring desalination plant at the end of the 30-day notice period.

(Apr 11): Olivia Lum is running out of time to save the company she spent a lifetime building.

SINGAPORE (Apr 10): ESR-REIT has been downgraded to “hold” from “buy” previously by OCBC Investment Research with a decreased fair value of 55 cents from 57.5 cents, on the back of lower returns and concerns regarding Hyflux Membrane.